Showing results (1021-1030 of 1,136) with videos related to

Sort By:
Pageof 114
Pediatric Blood & Cancer|December 28, 2020
Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemiaJohn C Molina, Julie M Asare, Laura Tuschong, et al.
American Journal of Industrial Medicine|August 4, 2025
Biomarkers of Kidney Function and Injury Across Fire Seasons and During a Mid-Season Fire Incident in the Wildland Firefighter Exposure and Health Effect (WFFEHE) StudyLynne E Pinkerton, Sara E Luckhaupt, Stephen Bertke, et al.
Journal of the American Chemical Society|July 24, 2008
Dynamic combinatorial discovery of a [2]-catenane and its guest-induced conversion into a molecular square hostKevin R West, R Fred Ludlow, Peter T Corbett, et al.
Nature Communications|April 19, 2019
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalkLiam B King, Brandyn R West, Crystal L Moyer, et al.
Infection Control and Hospital Epidemiology|March 27, 2018
A Generalizable, Data-Driven Approach to Predict Daily Risk of Clostridium difficile Infection at Two Large Academic Health CentersJeeheh Oh, Maggie Makar, Christopher Fusco, et al.
The American Journal of Medicine|March 20, 2013
Effects of clinical pathways for common outpatient infections on antibiotic prescribingTimothy C Jenkins, Amy Irwin, Letoynia Coombs, et al.
The Journal of Physiology|March 13, 2026
Acute cardio-centric haemodynamic management preserves chronic cardiovascular function in pigs with high-thoracic spinal cord injuryAlexandra M Williams, Neda Manouchehri, Keerit Tauh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Single-nucleus analysis reveals oxidative stress in Down syndrome basal forebrain neurons at birthNicole R West, Kalpana Hanthanan Arachchilage, Sara Knaack, et al.
Neurosurgery|December 16, 2025
Emergency TeleNeurosurgery Physician Consultation Program and Associated Health Care Utilization BenefitsEthan A Wetzel, Gregory Fournier, David Huckins, et al.
Scientific Reports|March 23, 2018
Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel DiseaseJ Scott Crowe, Kevin J Roberts, Timothy M Carlton, et al.
Pageof 114